Recall: D-0353-2023

Class II - Potentially Harmful

Class IIClassification
2023-02-06Initiated
TerminatedStatus
Alvogen, IncFirm

Product

Levothyroxine Sodium Tablets, USP 112 mcg, 90 tablets per bottle, Rx Only, Manufactured by Lloyd Inc., Shenandoah, IA, 51601, Distributed by: Alvogen Inc, Pine Brook, NJ 07058, NDC 47781-654-90.

Reason

Sub-Potent Drug: Out of specification for assay at the 24 month interval.

Distribution

Nationwide and Puerto Rico.

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.